Akebia Therapeutics reported $12.78M in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Akebia Therapeutics USD 12.78M 11.98M Sep/2026
Alnylam Pharmaceuticals USD 2.11B 358.58M Sep/2026
Amgen USD 51.61B 250M Sep/2026
Ardelyx USD 251.82M 48.31M Jun/2026
Astellas Pharma JPY 270B 50B Sep/2026
AstraZeneca USD 28.8B 2.79B Sep/2026
Bayer EUR 37.7B 6.54B Sep/2026
BioMarin Pharmaceutical USD 3.51B 12.96M Sep/2026
Celltrion KRW 412.88B 1.61B Jun/2026
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Fresenius Medical Care EUR 5.15B 676.78M Sep/2026
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
Ionis Pharmaceuticals USD 1.77B 140.62M Sep/2026
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 35.8B 1.55B Sep/2026
Kangmei Pharma CNY 67.35M 1.22M Jun/2026
Karyopharm Therapeutics USD 264.49M 13.73M Mar/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Lexicon Pharmaceuticals USD 49.68M 276K Mar/2026
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Moderna USD 3.55B 2.95B Sep/2026
Nektar Therapeutics USD 60.27M 2.89M Mar/2026
Organigram Holdings CAD 17.61M 43.15M Jun/2026
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 36.24M 4.11M Sep/2026
Prothena USD 0 0 Dec/2024
PTC Therapeutics USD 536.27M 749K Sep/2026
Qiagen NV USD 1.63B 19.45M Jun/2026
Regeneron Pharmaceuticals USD 1.99B 400K Sep/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 16.28B 1.63B Sep/2026
Sarepta Therapeutics USD 699.39M 148.23M Sep/2026
Sartorius EUR 3.43B 216.6M Sep/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tectonic Therapeutic USD 17K 26K Mar/2026
Tilray USD 268.59M 3.82M Sep/2025
Vanda Pharmaceuticals USD 3.15M 3.15M Dec/2024
Zealand Pharma A/S 307M 76.14M Mar/2026
Zz Pientze Pharmaceu CNY 160.45M 12.35M Sep/2026